BUTICAPS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Buticaps, and when can generic versions of Buticaps launch?
Buticaps is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in BUTICAPS is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BUTICAPS?
- What are the global sales for BUTICAPS?
- What is Average Wholesale Price for BUTICAPS?
Summary for BUTICAPS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 1,209 |
| DailyMed Link: | BUTICAPS at DailyMed |
US Patents and Regulatory Information for BUTICAPS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
